Documenti analoghi

• Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
  di: Koichi Ikeda, et al.
  Pubblicazione: (2025)
• Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes
  di: Teshamae S. Monteith, et al.
  Pubblicazione: (2025)
• Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Association: A pilot project
  di: Larry Charleston
  Pubblicazione: (2024)
• Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
  di: Jennifer Robblee, et al.
  Pubblicazione: (2024)
• Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study
  di: Jessica Ailani, et al.
  Pubblicazione: (2025)